The Dermamed Quadra Q4 with DES (Dry Eye Syndrome) is a medical grade Intense Pulsed Light technology specifically designed by innovator Dr. Rolando Toyos, MD, medical director and founder of the Toyos Clinic in Memphis, TN.
After many years of research supported by a grant from the American Society of Cataract and Refractive Surgery, Dr. Toyos refined this new approach for dry eye treatment, related to meibomian gland dysfunction, and the results have been exceptional. Rapid, powerful burst of light at specific wavelengths cause changes in blood vessels adjacent to the surface of the skin, increase the skin temperature and eliminates problematic flora on the skin and eyes, all of which have beneficial effects on meibomian gland dysfunction.
Prior to the Dermamed Quadra Q4 with DES IPL device, the existing technologies and IPL devices were inconsistent, and the bulb’s intensity would diminish over time. Dr. Toyos worked to solve these problems. “Now, we have an instrument that’s safe, with reproducible results,” he says. (Dr. Toyos emphasizes that doctors should not attempt this using just any IPL equipment.)
The first effect of the IPL dry eye treatment is the immediate heat, which acts like the “the best hot compress.” The light is absorbed in to the skin generating heat that melts down the thick secretions obstructing the gland opening. After the IPL treatment the glands are expressed removing the festered secretions. Giving most patients relief right away.
Research has also uncovered several other relevant effects of IPL dry eye treatment. Closing off the blood vessels near the surface of the skin decreases inflammatory cytokines that contribute to meibomian gland dysfunction. Evidence also suggests that IPL decreases and kills parasites on the eyelash margin (Demadex) that can cause meibomian gland problems.